Abstract
Potential complications from radiation therapy requiring supportive care measures include acute, subacute (also called early delayed), and chronic (late delayed) entities and are directly related to the site of radiation, subsequent dose, and volume of tissue exposed. Here we specifically concentrate on acute and, to a lesser extent, subacute issues. Data in children, especially of a prospective nature, are quite limited, and therefore we rely on extrapolation of data from adult studies which may or may not include pediatric patients. Studies on simple and widely utilized historical treatment strategies are often lacking; therefore, reference to clinical practice guidelines is made where possible. Radiation toxicity is examined in a site- and dose-dependent fashion with a discussion of supportive care evidence to date and recommendations on evidence-based treatment guidelines, where available.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abid SY, Malhotra V, Perry MC (2001) Radiation-induced and chemotherapy-induced pulmonary injury. Curr Opin Oncol 13:242–248
Abramoff MM, Lopes NN, Lopes LA et al (2008) Low-level laser therapy in the prevention and treatment of chemotherapy-induced oral mucositis in young patients. Photomed Laser Surg 26:393–400
Allen G, Logan R, Gue S (2010) Oral manifestations of cancer treatment in children: a review of the literature. Clin J Oncol Nurs 14:481–490
Archambeau JO, Pezner R, Wasserman T (1995) Pathophysiology of irradiated skin and breast. Int J Radiat Oncol Biol Phys 31:1171–1185
Barbería E, Hernandez C, Miralles V et al (2008) Paediatric patients receiving oncology therapy: review of the literature and management guidelines. Eur J Paediatr Dent 9:188–194
Basch E, Prestrud AA, Hesketh PJ et al (2011) Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 29:4189–4198
Basciano PA, Bussel JB (2012) Thrombopoietin-receptor agonists. Curr Opin Hematol 19:392–398
Becker-Schiebe M, Mengs U, Schaefer M et al (2011) Topical use of a silymarin-based preparation to prevent radiodermatitis. Strahlenther Onkol 187:485–491
Bennett CL, Silver SM, Djulbegovic B et al (2008) Venous thromboembolism and mortality associated with recombinant erythropoietin and darbopoietin administration for the treatment of cancer-associated anemia. JAMA 299:914–924
Bensadoun RJ, Patton LL, Lalla RV et al (2011) Oropharyngeal candidiasis in head and neck cancer patients treated with radiation: update 2011. Support Care Cancer 19:737–744
Berg RA, Ch’ien LT, Lancaster W et al (1983) Neuropsychological sequelae of postradiation somnolence syndrome. J Dev Behav Pediatr 4:103–107
Bernier J, Bonner J, Vermorken JB et al (2008) Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol 19:142–149
Bleyer A, Choi M, Wang SJ et al (2009) Increased vulnerability of the spinal cord to radiation or intrathecal chemotherapy during adolescence: a report from the Children’s Oncology Group. Pediatr Blood Cancer 53:1205–1210
Bohlius J, Wilson J, Seidenfeld J et al (2006) Recombinant human erythropoietins and cancer patients: updated meta-analysis of 57 studies including 9353 patients. J Natl Cancer Inst 98:708–714
Bolderston A, Lloyd NS, Wong RK et al (2006) The prevention and management of acute skin reactions related to radiation therapy: a systematic review and practice guidelines. Support Care Cancer 14:802–817
Bölling T, Ernst I, Pape H et al (2011) Dose-volume analysis of radiation nephropathy in children: preliminary report of the risk consortium. Int J Radiat Oncol Biol Phys 80:840–844
Bouyn CI, Leclere J, Raimondo G et al (2003) Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 97:3107–3113
Bradley J, Movsas B (2004) Radiation esophagitis: predictive factors and preventive strategies. Semin Radiat Oncol 14:280–286
Brizel DM, Dodge RK, Clough RW et al (1999) Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. Radiother Oncol 53:113–117
Budach W, Bölke E, Homey B (2007) Severe cutaneous reaction during radiation therapy with concurrent cetuximab. N Engl J Med 357:514–515
Bunn PA Jr, Crowley J, Kelly K et al (1995) Chemoradiotherapy with or without granulocyte-macrophage colony stimulating factor in the treatment of limited-stage small-cell lung cancer: a prospective phase III randomized study of the Southwest Oncology Group. J Clin Oncol 13:1632–1641
Burris HA 3rd, Hurtig J (2010) Radiation recall with anticancer agents. Oncologist 15:1227–1237
Bussel JB, Kuter DJ, George JN et al (2006) AMG 531, a thrombopoiesis-stimulating protein for chronic ITP. N Engl J Med 355:1672–1681
Butler JM, Rapp SR, Shaw EG (2006) Managing the cognitive effects of brain tumor radiation therapy. Curr Treat Options Oncol 7:517–523
Cassady JR (1995) Clinical radiation nephropathy. Int J Radiat Oncol Biol Phys 31:1249–1256
Center for International Blood and Marrow Transplant Research (CIBMTR), National Marrow Donor Program (NMDP), European Blood and Marrow Transplant Group (EBMT) et al (2009) Guidelines for preventing infectious complications among hematopoietic cell transplant recipients: a global perspective. Bone Marrow Transplant 44:453–558
Ch’ien LT, Aur RJ, Stanger S et al (1980) Long-term neurological implications of somnolence syndrome in children with acute lymphocytic leukemia. Ann Neurol 8:273–277
Chan RJ, Larsen E, Chan P (2012) Re-examining the evidence in radiation dermatitis management literature: an overview and a critical appraisal of systematic reviews. Int J Radiat Oncol Biol Phys 84:e357–e362
Chang EL, Allen P, Wu C et al (2002) Acute toxicity and treatment interruption related to electron and photon craniospinal irradiation in pediatric patients treated at the University of Texas M. D. Anderson Cancer Center. Int J Radiat Oncol Biol Phys 52:1008–1016
Chopra RR, Bogart JA (2009) Radiation therapy-related toxicity (including pneumonitis and fibrosis). Emerg Med Clin North Am 27:293–310
Clarkson JE, Worthington HV, Furness S et al (2010) Interventions for treating oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev (8):CD001973
Cox JD, Stetz J, Pajak TF (1995) Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31:1341–1346
Crawford J, Caserta C, Roila F et al (2009) Hematopoietic growth factors: ESMO recommendations for the applications. Ann Oncol 20:162–165
Dawson LA, Kavanagh BD, Paulino AC et al (2010) Radiation-associated kidney injury. Int J Radiat Oncol Biol Phys 76:S108–S115
Deasy JO, Moiseenko V, Marks L et al (2010) Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 76:S58–S63
Dekker A, Bulley S, Beyene J et al (2006) Meta-analysis of randomized controlled trials of prophylactic granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor after autologous and allogeneic stem cell transplantation. J Clin Oncol 24:5207–5215
Dewhirst MW, Cao Y, Moeller B (2008) Cycling hypoxia and free radicals regulate angiogenesis and radiotherapy response. Nat Rev Cancer 8:425–437
Dische S, Anderson PJ, Sealy R et al (1983) Carcinoma of the cervix–anaemia, radiotherapy and hyperbaric oxygen. Br J Radiol 56:251–255
Dunst J, Kuhnt T, Strauss HG et al (2003) Anemia in cervical cancers: impact on survival, patterns of relapse, and association with hypoxia and angiogenesis. Int J Radiat Oncol Biol Phys 56:778–787
Feight D, Baney T, Bruce S et al (2011) Putting evidence into practice: evidence-based interventions for radiation dermatitis. Clin J Oncol Nurs 15:481–492
Feyer PC, Maranzano E, Molassiotis A et al (2011) Radiotherapy-induced nausea and vomiting (RINV): MASCC/ESMO guideline for antiemetics in radiotherapy: update 2009. Support Care Cancer 19:S5–S14
Freeman JE, Johnston PG, Voke JM (1973) Somnolence after prophylactic cranial irradiation in children with acute lymphoblastic leukaemia. Br Med J 4:523–525
Fyles AW, Manchul L, Levin W et al (1998a) Effect of filgrastim (G-CSF) during chemotherapy and abdomino-pelvic radiation therapy in patients with ovarian carcinoma. Int J Radiat Oncol Biol Phys 41:843–847
Fyles AW, Milosevic M, Wong R et al (1998b) Oxygenation predicts radiation response and survival in patients with cervix cancer. Radiother Oncol 48:149–156
Gagliardi G, Constine LS, Moiseenko V et al (2010) Radiation dose-volume effects in the heart. Int J Radiat Oncol Biol Phys 76:S77–S85
Gernsheimer T (2008) The pathophysiology of ITP revisited: ineffective thrombopoiesis and the emerging role of thrombopoietin receptor agonists in the management of chronic immune thrombocytopenic purpura. Hematol Am Soc Hematol Educ Program:219–226
Gerstein J, Meyer A, Sykora KW et al (2009) Long-term renal toxicity in children following fractionated total-body irradiation (TBI) before allogeneic stem cell transplantation (SCT). Strahlenther Onkol 185:751–755
Gibson RJ, Keefe DM, Lalla RV et al (2013) Systematic review of agents for the management of gastrointestinal mucositis in cancer patients. Support Care Cancer 21:313–326
Grogan M, Thomas GM, Melamed I et al (1999) The importance of hemoglobin levels during radiotherapy for carcinoma of the cervix. Cancer 86:1528–1536
Guyatt G, Gutterman D, Baumann MH et al (2006) Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians Task Force. Chest 129:174–181
Harris AL (2002) Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2:38–47
Harrison L, Blackwell K (2004) Hypoxia and anemia: factors in decreased sensitivity to radiation therapy and chemotherapy? Oncologist 9:31–40
Henke M, Alfonsi M, Foa P et al (2011) Palifermin decreases severe oral mucositis of patients undergoing postoperative radiochemotherapy for head and neck cancer: a randomized, placebo-controlled trial. J Clin Oncol 29:2815–2820
Hensley ML, Hagerty KL, Kewalramani T et al (2009) American Society of Clinical Oncology 2008 clinical practice guideline update: use of chemotherapy and radiation therapy protectants. J Clin Oncol 27:127–145
Hoff CM, Hansen HS, Overgaard M et al (2011a) The importance of haemoglobin level and effect of transfusion in HNSCC patients treated with radiotherapy—results from the randomized DAHANCA 5 study. Radiother Oncol 98:28–33
Hoff CM, Lassen P, Eriksen JG et al (2011b) Does transfusion improve the outcome for HNSCC patients treated with radiotherapy?—results from the randomized DAHANCA 5 and 7 trials. Acta Oncol 50:1006–1014
Hoskin PJ, Robinson M, Slevin N et al (2009) Effect of epoetin alfa on survival and cancer treatment-related anemia and fatigue in patients receiving radical radiotherapy with curative intent for head and neck cancer. J Clin Oncol 27:5751–5756
Hovan AJ, Williams PM, Stevenson-Moore P et al (2010) A systematic review of dysgeusia induced by cancer therapies. Support Care Cancer 18:1081–1087
Huang E, Teh BS, Strother DR et al (2002) Intensity-modulated radiation therapy for pediatric medulloblastoma: early report on the reduction of ototoxicity. Int J Radiat Oncol Biol Phys 52:599–605
Jensen SB, Pedersen AM, Vissink A et al (2010a) A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: prevalence, severity and impact on quality of life. Support Care Cancer 18:1039–1060
Jensen SB, Pedersen AM, Vissink A et al (2010b) A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer 18:1061–1079
Jensen SB, Jarvis V, Zadik Y et al (2013) Systematic review of miscellaneous agents for the management of oral mucositis in cancer patients. Support Care Cancer 21:3223–3232
Kalaghchi B, Kazemian A, Hassanloo J et al (2010) Granulocyte colony stimulating factor for prevention of craniospinal radiation treatment interruption among central nervous system tumor patients. Asian Pac J Cancer Prev 11:1499–1502
Kavanagh BD, Pan CC, Dawson LA et al (2010) Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys 76:S101–S107
Kedge EM (2009) A systematic review to investigate the effectiveness and acceptability of interventions for moist desquamation in radiotherapy patients. Radiography 15:247–257
Keefe DM, Schubert MM, Elting LS et al (2007) Updated clinical practice guidelines for the prevention and treatment of mucositis. Cancer 109:820–831
Keime-Guibert F, Napolitano M, Delattre JY (1998) Neurological complications of radiotherapy and chemotherapy. J Neurol 245:695–708
Kelsey CR, Marks LB (2006) Somnolence syndrome after focal radiation therapy to the pineal region: case report and review of the literature. J Neurooncol 78:153–156
Kielbassa AM, Hinkelbein W, Hellwig E et al (2006) Radiation-related damage to dentition. Lancet Oncol 7:326–335
Kirkpatrick JP, van der Kogel AJ, Schultheiss TE (2010) Radiation dose-volume effects in the spinal cord. Int J Radiat Oncol Biol Phys 76:S42–S49
Krasin MJ, Hoth KA, Hua C et al (2009) Incidence and correlates of radiation dermatitis in children and adolescents receiving radiation therapy for the treatment of paediatric sarcomas. Clin Oncol 21:781–785
Kumar S, Juresic E, Barton M et al (2010) Management of skin toxicity during radiation therapy: a review of the evidence. J Med Imaging Radiat Oncol 54:264–279
Kuter DJ (2007) New thrombopoietic growth factors. Blood 109:4607–4616
Ladas EJ, Sacks N, Meacham L et al (2005) A multidisciplinary review of nutrition considerations in the pediatric oncology population: a perspective from Children’s Oncology Group. Nutr Clin Pract 20:377–393
Lambin P, Ramaekers BL, van Mastrigt GA et al (2009) Erythropoietin as an adjuvant treatment with (chemo) radiation therapy for head and neck cancer. Cochrane Database Sys Rev (8):CD006158
Lawrence TS, Robertson JM, Anscher MS et al (1995) Hepatic toxicity resulting from cancer treatment. Int J Radiat Oncol Biol Phys 31:1237–1248
Lawrence YR, Li XA, el Naqa I et al (2010) Radiation dose-volume effects in the brain. Int J Radiat Oncol Biol Phys 76:S20–S27
Le QT, Kim HE, Schneider CJ et al (2011) Palifermin reduces severe mucositis in definitive chemoradiotherapy of locally advanced head and neck cancer: a randomized, placebo-controlled study. J Clin Oncol 29:2808–2814
Littman P, Rosenstock J, Gale G et al (1984) The somnolence syndrome in leukemic children following reduced daily dose fractions of cranial radiation. Int J Radiat Oncol Biol Phys 10:1851–1853
MacManus MP, Clarke J, McCormick D et al (1993) Use of recombinant granulocyte-colony stimulating factor to treat neutropenia occurring during craniospinal irradiation. Int J Radiat Oncol Biol Phys 26:845–850
MacManus MP, McCormick D, Trimble A et al (1995) Value of granulocyte colony stimulating factor in radiotherapy induced neutropenia: clinical and laboratory studies. Eur J Cancer 31A:302–307
MacManus M, Lamborn K, Khan W et al (1997) Radiotherapy-associated neutropenia and thrombocytopenia: analysis of risk factors and development of a predictive model. Blood 89:2303–2310
Mahboubi S, Silber JH (1997) Radiation-induced esophageal strictures in children with cancer. Eur Radiol 7:119–122
Mandell LR, Walker RW, Steinherz P et al (1989) Reduced incidence of the somnolence syndrome in leukemic children with steroid coverage during prophylactic cranial radiation therapy. Cancer 63:1975–1978
Marec-Berard P, Chastagner P, Kassab-Chahmi D et al (2009) 2007 standards, options, and recommendations: use of erythropoiesis-stimulating agents (ESA: epoetin alfa, epoetin beta, and darbopoietin) for the management of anemia in children with cancer. Pediatr Blood Cancer 53:7–12
Marks LB, Carroll PR, Dugan TC et al (1995) The response of the urinary bladder, urethra, and ureter to radiation and chemotherapy. Int J Radiat Oncol Biol Phys 31:1257–1280
Marks LB, Bentzen SM, Deasy JO et al (2010) Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 76:S70–S76
Mauch P, Constine L, Greenberger J et al (1995) Hematopoietic stem cell compartment: acute and late effects of radiation therapy and chemotherapy. Int J Radiat Oncol Biol Phys 31:1319–1339
Mayo C, Yorke E, Merchant TE (2010) Radiation associated brainstem injury. Int J Radiat Oncol Biol Phys 76:S36–S41
McDonald S, Rubin P, Phillips TL et al (1995) Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 31:1187–1203
McGuire DB, Fulton JS, Park J et al (2013) Systematic review of basic oral care for the management of oral mucositis in cancer patients. Support Care Cancer 21:3165–3177
McQuestion M (2011) Evidence-based skin care management in radiation therapy: clinical update. Semin Oncol Nurs 27:e1–e17
Merchant TE, Bosley C, Smith J et al (2007) A phase III trial comparing an anionic phospholipid-based cream and aloe vera-based gel in the prevention of radiation dermatitis in pediatric patients. Radiat Oncol 2:45
Michalski JM, Gay H, Jackson A et al (2010) Radiation dose-volume effects in radiation-induced rectal injury. Int J Radiat Oncol Biol Phys 26:S123–S129
Migliorati C, Hewson I, Lalla RV et al (2013) Systematic review of laser and other light therapy for the management of oral mucositis in cancer patients. Support Care Cancer 21:333–341
Miyahara M, Azuma E, Hirayama M et al (2000) Somnolence syndrome in a child following 1200-cGy total body irradiation in an unrelated bone marrow transplantation. Pediatr Hematol Oncol 17:489–495
New P (2001) Radiation injury to the nervous system. Curr Opin Neurol 14:725–734
Nicolatou-Galitis O, Sarri T, Bowen J et al (2013a) Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients. Support Care Cancer 21:3179–3189
Nicolatou-Galitis O, Sarri T, Bowen J et al (2013b) Systematic review of amifostine for the management of oral mucositis in cancer patients. Support Care Cancer 21:357–364
Ning S, Hartley C, Molineux G et al (2005) Darbepoietin alfa potentiates the efficacy of radiation therapy in mice with corrected or uncorrected anemia. Cancer Res 65:284–290
Nordsmark M, Overgaard J (2004) Tumor hypoxia is independent of hemoglobin and prognostic for loco-regional tumor control after primary radiotherapy in advanced head and neck cancer. Acta Oncol 43:396–403
Nordsmark M, Bentzen SM, Rudat V et al (2005) Prognostic value of tumor oxygenation in 397 head and neck tumors after primary radiation therapy. An international multi-center study. Radiother Oncol 77:18–24
Otmani N (2007) Oral and maxillofacial side effects of radiation therapy on children. J Can Dent Assoc 73:257–261
Overgaard J (2007) Hypoxic radiosensitization: adored and ignored. J Clin Oncol 25:4066–4074
Overgaard J, Horsman MR (1996) Modification of hypoxia-induced radioresistance in tumors by the use of oxygen and sensitizers. Semin Radiat Oncol 6:10–21
Pan CC, Kavanagh BD, Dawson LA et al (2010) Radiation-associated liver injury. Int J Radiat Oncol Biol Phys 76:S94–S100
Parker D, Malpas JS, Sandland R et al (1978) Outlook following “somnolence syndrome” after prophylactic cranial irradiation. Br Med J 1:554
Payne H, Adamson A, Bahl A et al (2013) Chemical- and radiation-induced haemorrhagic cystitis: current treatments and challenges. BJU Int 112:885–897
Peterson DE, Bensadoun RJ, Rolla F et al (2011) Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Ann Oncol 22:vi78–vi84
Peterson DE, Öhrn K, Bowen J et al (2013) Systematic review of oral cryotherapy for management of oral mucositis caused by cancer therapy. Support Care Cancer 21:327–332
Pinel S, Barberi-Heyob M, Cohen-Jonathan E et al (2004) Erythropoietin-induced reduction of hypoxia before and during fractionated irradiation contributes to improvement of radioresponse in human glioma xenografts. Int J Radiat Oncol Biol Phys 59:250–259
Powell C, Guerrero D, Sardell S et al (2011) Somnolence syndrome in patients receiving radical radiotherapy for primary brain tumors: a prospective study. Radiother Oncol 100:131–136
Prosnitz RG, Yao B, Farrell CL et al (2005) Pretreatment anemia is correlated with the reduced effectiveness of radiation and concurrent chemotherapy in advanced head and neck cancer. Int J Radiat Oncol Biol Phys 61:1087–1095
Qutob AF, Allen G, Gue S et al (2013a) Implementation of a hospital oral care protocol and recording of oral mucositis in children receiving cancer treatment. Support Care Cancer 21:1113–1120
Qutob AF, Gue S, Revesz T et al (2013b) Prevention of oral mucositis in children receiving cancer therapy: a systematic review and evidence-based analysis. Oral Oncol 49:102–107
Raber-Durlacher JE, von Bültzingslöwen I, Logan RM et al (2013) Systematic review of cytokines and growth factors for the management of oral mucositis in cancer patients. Support Care Cancer 21:343–355
Rancati T, Schwarz M, Allen AM et al (2010) Radiation dose-volume effects in the larynx and pharynx. Int J Radiat Oncol Biol Phys 76:S64–S69
Rinne ML, Lee EQ, Wen PY (2012) Central nervous system complications of cancer therapy. J Support Oncol 10:133–141
Rizzo JD, Brouwers M, Hurley P et al (2010) American Society of Hematology/American Society of Clinical Oncology clinical practice guideline update on the use of epoetin and darbepoetin in adult patients with cancer. Blood 116:4045–4059
Saarilahti K, Kouri M, Collan J et al (2006) Sparing of the submandibular glands by intensity modulated radiotherapy treatment of head and neck cancer. Radiother Oncol 78:270–275
Salvo N, Barnes E, van Draanen J et al (2010) Prophylaxis and management of acute radiation-induced skin reactions: a systematic review of the literature. Curr Oncol 17:94–112
Saunders DP, Epstein JB, Elad S et al (2013) Systematic review of antimicrobials mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients. Support Care Cancer 21:3191–3207
Smith T, Khatcheressian J, Lyman G et al (2006) 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 24:3187–3205
Sonis ST, Elting LS, Keefe D et al (2004) Perspective on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer 100:1995–2025
Soussain C, Ricard D, Fike JR et al (2009) CNS complications of radiotherapy and chemotherapy. Lancet 374:1639–1651
Srinivasan A, Kasow KA, Cross S et al (2012) Phase I study of the tolerability and pharmacokinetics of palifermin in children undergoing allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 18:1309–1314
Stüben G, Thews O, Pöttgen C et al (2003) Impact of anemia prevention by recombinant human erythropoietin on the sensitivity of xenografted glioblastomas to fractionated irradiation. Strahlenther Onkol 179:620–625
Su YB, Vickers AJ, Zelefsky MJ et al (2006) Double-blind, placebo-controlled, randomized trial of granulocyte-colony stimulating factor during postoperative radiotherapy for squamous head and neck cancer. Cancer J 12:182–188
Sung L, Nathan PC, Alibhai SM et al (2007a) Meta-analysis: effect of prophylactic hematopoietic colony-stimulating factors on mortality and outcomes of infection. Ann Intern Med 147:400–411
Sung L, Tomlinson GA, Greenberg ML et al (2007b) Validation of the oral mucositis assessment scale in pediatric cancer. Pediatr Blood Cancer 49:149–153
Thomas G (2001) The effect of hemoglobin level on radiotherapy outcomes: the Canadian experience. Semin Oncol 28:60–65
Thomas G, Ali S, Hoebers FJ et al (2008) Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer. Gynecol Oncol 108:317–325
Tomlinson D, Judd P, Hendershot E et al (2007) Measurement of oral mucositis in children: a review of the literature. Support Care Cancer 15:1251–1258
Trotti A, Colevas AD, Setser A et al (2003) CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13:176–181
Uzal D, Özyar E, Hayran M et al (1998) Reduced incidence of the somnolence syndrome after prophylactic cranial irradiation in children with acute lymphoblastic leukemia. Radiother Oncol 48:29–32
Vaupel P (2008) Hypoxia and aggressive tumor phenotype: implications for therapy and prognosis. Oncologist 13:21–26
Vaupel P, Harrison L (2004) Tumor hypoxia: causative factors, compensatory mechanisms, and cellular response. Oncologist 9:4–9
Vaupel P, Thews O, Hoeckel M (2001) Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 18:243–259
Vern TZ, Salvi S (2009) Somnolence syndrome and fever in pediatric patients with cranial irradiation. J Pediatr Hematol Oncol 31:118–120
Viswanathan AN, Yorke ED, Marks LB et al (2010) Radiation dose-volume effects of the urinary bladder. Int J Radiat Oncol Biol Phys 76:S116–S122
Weiner DJ, Maity A, Carlson CA et al (2006) Pulmonary function abnormalities in children treated with whole lung irradiation. Pediatr Blood Cancer 46:222–227
Werner-Wasik M, Yorke E, Deasy J et al (2010) Radiation dose-volume effects in the esophagus. Int J Radiat Oncol Biol Phys 76:S86–S93
Wong EC, Perez-Albueme E, Moscow JA et al (2005) Transfusion management strategies: a survey of practicing pediatric hematology/oncology specialists. Pediatr Blood Cancer 44:119–127
Wong RK, Bensadoun RJ, Boers-Doets CB et al (2013) Clinical practice guidelines for the prevention and treatment of acute and late radiation reactions from the MASCC Skin Toxicity Study Group. Support Care Cancer 21:2933–2948
Worthington HV, Clarkson JE, Bryan G et al (2011) Interventions for preventing oral mucositis for patients with cancer receiving treatment. Cochrane Database Syst Rev (4):CD000978
Yarom N, Ariyawardana A, Hovan A et al (2013) Systematic review of natural agents for the management of oral mucositis in cancer patients. Support Care Cancer 21:3209–3221
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer Berlin Heidelberg
About this chapter
Cite this chapter
Chung, J.H., Agrawal, A.K., Swift, P.S. (2015). Management of Acute Radiation Side Effects. In: Feusner, J., Hastings, C., Agrawal, A. (eds) Supportive Care in Pediatric Oncology. Pediatric Oncology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44317-0_13
Download citation
DOI: https://doi.org/10.1007/978-3-662-44317-0_13
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44316-3
Online ISBN: 978-3-662-44317-0
eBook Packages: MedicineMedicine (R0)